IncobotulinumtoxinA for Migraine: A Retrospective Case Series

Headache Disorders. WHO. Web. Accessed 8 Aug 2014 http://www.who.int/mediacentre/factsheets/fs277/en/ QuickStats: Percentage of Adults Who Had Migraines or Severe Headaches, Pain in the Neck, Lower Back, or Face/Jaw, by Sex—National Health Interview Survey, 2009. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 03 Dec. 2010. Web. Accessed 8 Aug 2014. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5947a6.htm Stovner, 2014, The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache, J Headache Pain, 15, 5, 10.1186/1129-2377-15-5 Olesen, 2006, New appendix criteria open for a broader concept of chronic migraine, Cephalalgia, 26, 6742, 10.1111/j.1468-2982.2006.01172.x Silberstein, 2000, Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group, Headache, 40, 445, 10.1046/j.1526-4610.2000.00066.x Allergan Inc, 2013 Aurora, 2014, OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program, Acta Neurol Scand, 129, 61, 10.1111/ane.12171 Ashkenazi, 2004, Botulinum toxin and other new approaches to migraine therapy, Annu Rev Med, 55, 505, 10.1146/annurev.med.55.091902.104440 Burstein, 2014, Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains, Cephalalgia, 34, 853, 10.1177/0333102414527648 Jandhyala, 2012, Relative potency of incobotulinumtoxinA vs onabotulinumtoxinA a meta-analysis of key evidence, J Drugs Dermatol, 11, 731 Rappl, 2013, Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study, Clin Cosmet Investig Dermatol, 6, 211, 10.2147/CCID.S41537 Hjermstad, 2011, Studies comparing numerical rating scales, verbal rating scales, and visual analog scales for assessment of pain intensity in adults: a systematic literature review, J Pain Symptom Manage, 41, 1073, 10.1016/j.jpainsymman.2010.08.016 Merz, 2014 Kazerooni, 2015, Cost utility analysis of botulinum toxin type A products for the treatment of cervical dystonia, Am J Health Syst Pharm, 72, 301, 10.2146/ajhp140276